Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to -$17.58.

  • iSpecimen's EPS (Weighted Average and Diluted) rose 77.14% to -$0.48 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.89, marking a year-over-year increase of 58.36%. This contributed to the annual value of -$17.58 for FY2024, which is 28.39% up from last year.
  • Per iSpecimen's latest filing, its EPS (Weighted Average and Diluted) stood at -$17.58 for FY2024, which was up 28.39% from -$24.55 recorded in FY2023.
  • In the past 5 years, iSpecimen's EPS (Weighted Average and Diluted) registered a high of -$1.16 during FY2022, and its lowest value of -$24.55 during FY2023.
  • In the last 3 years, iSpecimen's EPS (Weighted Average and Diluted) had a median value of -$17.58 in 2024 and averaged -$14.43.
  • As far as peak fluctuations go, iSpecimen's EPS (Weighted Average and Diluted) skyrocketed by 57.95% in 2021, and later slumped by 2,016.38% in 2023.
  • iSpecimen's EPS (Weighted Average and Diluted) (Yearly) stood at -$4.97 in 2020, then soared by 57.95% to -$2.09 in 2021, then skyrocketed by 44.50% to -$1.16 in 2022, then plummeted by 2,016.38% to -$24.55 in 2023, then rose by 28.39% to -$17.58 in 2024.